Venus Remedies Income Statement

Quarterly

Yearly

home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
20212022
EBITDA7370
EBIT6237
Earning Per Share5030
Expenses494537
Net Profit6241
Net Profit Margin117
Operating Profit Margin1312
Profit Before Tax4936
Dividends Per Share00
Operation Revenue568607

Peer Comparison (in ₹.Cr.)

CompanyYearEBITEBITDANet ProfitNet WorthProfit Before Tax
2023008,560.84NA9,408.43
2023002,835.49NA4,038.35
202300372.90NA385.50
202300103.87NA140.39
20221,257.602,182.90978.507,628.101,190
The EBITDA of Venus Remedies is 70 as of 3/2/2024
home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
20182019202020212023
Operating Activities31457813237
Investing Activities-11-11-556-51
Financing Activities-39-35-73-162-1
Others00000
Net Cash Flow-20-1-026-15

Peer Comparison (in ₹.Cr.)

CompanyYearOperating ActivitiesInvesting ActivitiesFinancing ActivitiesNet Cash Flow
20234,959.33-7,943.682,376.07-608.28
20203,068.45104.04-2,948.82223.67
2018312.42-884.38502.63-69.33
2020140.90-44.50-38.5557.85
2017640-498.50-177.50-36
The cash flow from Operating Activities of Venus Remedies is 37 as of 3/2/2024